Notices of approved & permitted restricted representations

Therapeutic goods advertisements to consumers may not refer to a serious form of a disease, condition, ailment or defect as specified in Appendix 6 of the Therapeutic Goods Advertising Code. These are known as restricted representations.

In some cases the Secretary can approve (under Section DF of the Therapeutic Goods Act 1989) or permit (under Section 42DK(1)) the use of a restricted representation.

Exemptions can also be withdrawn under Section 42DI of the Therapeutic Goods Act 1989.

Here are the written notices of approval or permission for the use of restricted representations in advertising therapeutic goods to consumers.

  • 13 September 2002
    Notice of advertising exemption under Regulation 7C (1) of the Therapeutic Goods Regulations for broad spectrum 30+ sunscreens
  • 30 April 2002
    Notice of advertising exemption under Regulation 7C (1) of the Therapeutic Goods Regulations for metamucil
  • 19 February 2001
    Notice of advertising exemption under Regulation 7C (1) of the Therapeutic Goods Regulations for Panadol

Withdrawn advertising exemptions (Section 42DI)

After the Secretary has granted approval to use a restricted representation in advertising to consumers, there are a number of circumstances under which the Secretary may subsequently withdraw the approval. These circumstances are described within Section 42DI of the Therapeutic Goods Act.